NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.85 -0.07 (-2.40%)
At close: Oct 1, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Gross Margin (2025 - 2026)

Updated

NRX Pharmaceuticals (NRXP) posted Gross Margin of 38.69% for Q2 2026, down 3.94 percentage points from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Gross Margin (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Gross Margin at NRX Pharmaceuticals was 47.14%; for FY2025, it was 58.78%.

  • According to Business Quant data, Gross Margin for the three prior quarters was 42.64% (Q1 2026), 58.49% (Q4 2025) and 59.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 68.19%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 74.74%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 73.54%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 78.02%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 83.60%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 72.04%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 79.76%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 72.78%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 85.33%
10 NRX Pharmaceuticals 126.02 Mn 77.61 Mn 426,000.00 38.69%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.69%
Mar 31, 2026 42.64%
Dec 31, 2025 58.49%
Sep 30, 2025 59.92%
API Access

NRX Pharmaceuticals Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=NRXP&period=max&api_key=YOUR_API_KEY